Cary Street Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,299
Closed -$182K 975
2025
Q3
$182K Hold
12,299
﹤0.01% 810
2025
Q2
$186K Hold
12,299
0.01% 785
2025
Q1
$177K Hold
12,299
0.01% 772
2024
Q4
$186K Buy
+12,299
New +$198K 0.01% 735

Other funds holding BCAT

Cary Street Partners's BCAT Position: Q4 2025 in Review

Cary Street Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2025, closing a stake of 12,299 shares — an estimated $182K sold.

Cary Street Partners first reported a position in BCAT in Q4 2024 and held it in 4 quarters. The position peaked at $186K in Q4 2024. 106 funds tracked by Wall St. Rank hold BCAT as of Q4 2025.

  • Cary Street Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2025 after selling out during the quarter.
  • Cary Street Partners sold 12,299 BlackRock Capital Allocation Term Trust shares in Q4 2025, an estimated $182K.
  • Cary Street Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2024 and held it in 4 quarters.
  • Cary Street Partners's BlackRock Capital Allocation Term Trust position peaked at $186K in Q4 2024.
  • 106 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2025.

Based on Cary Street Partners's 13F filing for Q4 2025, filed 9 Feb 2026.